Skip to main content
. Author manuscript; available in PMC: 2015 Feb 5.
Published in final edited form as: Antivir Ther. 2014 Oct 13;19(0 3):15–29. doi: 10.3851/IMP2897

Figure 6.

Figure 6

Representative critical materials in antiretroviral API manufacturing

API, active pharmaceutical ingredient; ATV, atazanavir; AZT, zidovudine; DRV, darunavir; EFV, efavirenz; FTC, emtricitabine; LPV, lopinavir; RTV, ritonavir; TDF, tenofovir disoproxil fumarate.